Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Share News (RENX)

Share Price Information for Renalytix Plc (RENX)

Share Price is delayed by 15 minutes
Get Live Data
1.80    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (25.00%)
Market Cap: £7.87m
RENX Live PriceLast checked at - London Stock Exchange

Intraday Renalytix Plc Share Chart

Renalytix Plc News

TRADING UPDATES: Avation extends easyJet lease; Abingdon wins deal
6 Jun 2022

TRADING UPDATES: Avation extends easyJet lease; Abingdon wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

IN BRIEF: Renalytix raises USD26.8 million through share subscription
8 Apr 2022

IN BRIEF: Renalytix raises USD26.8 million through share subscription

Renalytix PLC - London-based diagnostics company focused on kidney health - Completes a USD8.8 million equity subscription and a USD21.2 million subsc...

Renalytix completes financing to support its growth
8 Apr 2022

Renalytix completes financing to support its growth

(Sharecast News) - Renalytix announced the completion of a $30m (£23.06m) financing package on Friday, to support its growth and for general work...

Revenue rises, losses widen in first half at Renalytix
31 Mar 2022

Revenue rises, losses widen in first half at Renalytix

(Sharecast News) - Artificial intelligence (AI)-focussed diagnostics company Renalytix reported first-half revenue of $1.3m (£0.99m) in its first...

IN BRIEF: Renalytix jumps on increased revenue and financing package
31 Mar 2022

IN BRIEF: Renalytix jumps on increased revenue and financing package

Renalytix PLC - London-based diagnostics company focused on kidney health - Reports a widened pretax loss of USD26.8 million for the six months to Dec...

Renalytix hits patient milestone for kidney and diabetes 'biorepository'
29 Mar 2022

Renalytix hits patient milestone for kidney and diabetes 'biorepository'

(Sharecast News) - Renalytix announced on Tuesday that it has reached an enrollment milestone for its kidney disease and diabetes medicine platform.

Renalytix launches new US provider access portal
9 Mar 2022

Renalytix launches new US provider access portal

(Sharecast News) - Renalytix announced the launch of the new 'myIntelX' provider access portal on Wednesday, to provide access for United States physi...

Renalytix shares soar as it launches provider access portal myIntelX
9 Mar 2022

Renalytix shares soar as it launches provider access portal myIntelX

(Alliance News) - Renalytix PLC shares soared on Wednesday after the company said it launched its new provider access portal myIntelX in the UK.